After the price cut, coronary stents will be implemented in all provinces by the end of January.
The reporter learned from the National Health Protection Bureau that as of January 9, the results of the centralized banded procurement of coronary stents organized by the state were officially implemented in 23 provinces and municipalities, including Beijing and Tianjin, where patients used coronary stents after the centralized procurement.
The national organization of coronary stent centralized banded procurement landing implementation of 23 provinces and municipalities, including Beijing, Tianjin, Hebei, Shanxi, Inner Mongolia, Liaoning, Jilin, Heilongjiang, Jiangsu, Zhejiang, Fujian, Jiangxi, Shandong, Hubei, Hunan, Guangdong, Hainan, Guizhou, Yunnan, Gansu, Qinghai, Ningxia, Xinjiang.
It is understood that each year in China, about more than 1 million patients with coronary heart disease need to be implanted coronary heart stents, 2020 early November to produce the results of the selection, 10 selected varieties, from the average price of 13,000 yuan to about 700 yuan, a reduction of more than 90%, is expected to save the health insurance fund of 10.9 billion yuan, the patient's out-of-pocket payment will also be reduced.
Expanded:
It is understood that in order to ensure that the coronary stent price reduction does not reduce the quality of the coronary stent, coronary stent band purchasing fully respect the clinical use of customary, by the medical institutions in the province of the public **** resources trading platform to choose the winning products, clear distribution companies, the implementation of the implementation of the failure to guarantee the quality and quantity of behavior, such as the quality and quantity, will be Claims, discipline, withdrawal, alternative and emergency safeguard measures to ensure the safety of patient use.
Li Feng, director of the third cardiovascular internal medicine department of Changsha No. 3 Hospital and chief physician, introduced that the quality of the stents after the price cut is not different from the previous ones.
Lei Dongzhu, director of the First People's Hospital of Chenzhou City, said that coronary stents, which are often called heart stents, are highly utilized in the treatment of heart diseases, with one to three of them being used in each surgery. Due to its high price, it not only brings considerable cost pressure to patients, but also accounts for a higher proportion of the health insurance fund due to its large dosage.
November 5, 2020, the national centralized banded procurement policy for coronary stents was introduced, and the hospital strictly followed the documents of the state and relevant departments of Hunan, and the equipment department of the hospital and the relevant clinical departments also actively made relevant preparations.
At present, the prices of the three coronary stents in Chenzhou First People's Hospital's banded procurement have been updated, and the rate of reduction is obvious. Among them, the drug-coated stent system (rapamycin) has been lowered from 14,900 yuan to 469 yuan, which is the lowest price among the selected products in this banded procurement.
ThousandDragon.com - Coronary stents have landed in 23 provinces and municipalities after the price reduction, and all of them will be landed and implemented nationwide at the end of January